Endra Life Sciences GAAP EPS of -$56.94
Source: SeekingAlpha
2025-03-31 08:14:55 ET
More on Endra Life Sciences
- Seeking Alpha’s Quant Rating on Endra Life Sciences
- Historical earnings data for Endra Life Sciences
- Financial information for Endra Life Sciences
Read the full article on Seeking Alpha
For further details see:
Endra Life Sciences GAAP EPS of -$56.94
ENDRA Life Sciences Inc.
NASDAQ: NDRA
NDRA Trading
0.92% G/L:
$3.3305 Last:
3,155 Volume:
$3.32 Open:
NDRA Latest News
February 26, 2026 08:00:00 am
ENDRA's TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
December 04, 2025 08:00:00 am
ENDRA's TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
November 20, 2025 08:00:00 am
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
NDRA Stock Data
$4,362,489
934,319
31.12%
6
N/A
Medical Diagnostics & Screening
Healthcare
US
Ann Arbor
